Category:

Medtronic Executive to Lead Teleflex After Portfolio Divestitures

Teleflex has appointed Jason Weidman as President and Chief Executive Officer, effective June 8, placing a longtime Medtronic executive at the helm as the company reshapes its portfolio around higher-focus medtech markets. Weidman spent nearly two decades at Medtronic, most recently serving as SVP and President of the Coronary & Renal Denervation and Aortic, Peripheral, and Venous businesses. He succeeds Stuart Randle, who has served as interim CEO since January and will remain on Teleflex’s Board of Directors…

Posted On :
Category:

Amplitude Appoints ServiceNow Executive Gab Menachem as Chief Product Officer

Amplitude has appointed Gab Menachem as Chief Product Officer as the company expands its AI analytics strategy. Menachem founded Loom Systems, an AIOps company acquired by ServiceNow in 2020, and later spent six years helping scale ServiceNow’s IT Operations Management product line to more than $1 billion in annual revenue. At Amplitude, he will oversee product management, design, and growth, reporting to co-founder and CEO Spenser Skates…

Posted On :
Category:

Viz.ai and NRHA Aim to Close Technology Gap for Rural Hospitals

A partnership between Viz.ai and the National Rural Health Association (NRHA) is set to bring life-saving artificial intelligence to America’s most underserved medical frontiers. Launched on April 30, 2026, the initiative targets a stark “technology canyon”: research indicates that rural hospitals are currently 25% less likely to adopt advanced tools like AI than their urban counterparts, often due to thin budgets and a lack of on-site specialists…

Posted On :
Category:

Former Baxter Chief Takes Helm After Blackstone-TPG Take-Private

Hologic has appointed José “Joe” Almeida as CEO following the completion of its acquisition by Blackstone and TPG. Almeida succeeds Stephen MacMillan, who retired after more than 12 years leading the women’s health company. The $18.3 billion take-private deal gives Hologic new ownership as it weighs product innovation, acquisitions, and longer-term growth outside the pressures of the public market…

Posted On :
Category:

Ambience Healthcare Appoints Michael Han as Chief Medical Officer

Ambience Healthcare appointed Michael Han, MD, MBA, as Chief Medical Officer. Dr. Han joins the San Francisco-based firm following a successful tenure as enterprise chief medical information officer at MultiCare Health System. At MultiCare, he was the primary architect for clinical informatics and EHR strategy across a massive integrated delivery network, managing enterprise application governance and large-scale technology deployments…

Posted On :
Category:

Oportun Taps Consumer Credit Expert Doug Bland to Drive Scale

Oportun Financial has appointed Doug Bland as Chief Executive Officer, concluding a search for a leader to steer the mission-driven fintech through its next growth phase. In this role, Bland will oversee Oportun’s technology-driven platform, which provides credit and financial services to borrowers often overlooked by traditional lenders. He will be responsible for strengthening the company’s financial foundation and deepening member relationships as Oportun focuses on achieving sustainable profitability and long-term shareholder value…

Posted On :
Category:

Sovos Appoints Fintech Veteran David McCann as Chief Technology Officer

Sovos has appointed David McCann as Chief Technology Officer, signaling a deeper push toward autonomous, AI-driven tax reporting. McCann arrives with an extensive background in the fintech and SaaS sectors, most recently serving as CTO at Self Financial. During his tenure there, he led a platform modernization that overhauled the company’s fintech infrastructure and improved delivery speed and system resilience…

Posted On :
Category:

Pfizer Strategist Andrew Baum Shifts to Senior Advisor Role Under Bourla

Pfizer Chief Strategy and Innovation Officer Andrew Baum is stepping down from his executive position to serve as a senior strategic advisor to CEO Albert Bourla. Baum, a former top-tier equity research analyst, joined the pharmaceutical giant in 2024 to provide an outside-in perspective on the company’s portfolio. He will support the executive team through the end of the year before departing the company entirely. Analysts view the move as part of a broader “operational simplification” as the New York-based drugmaker streamlines its leadership structure following a period of massive post-pandemic realignment…

Posted On :
Category:

LinkedIn Appoints Longtime Executive Dan Shapero as Chief Executive Officer

Microsoft has promoted Dan Shapero to Chief Executive Officer of LinkedIn, elevating a veteran leader who has been instrumental in the platform’s growth since 2008. Shapero previously served as chief operating officer and has held senior roles across product, sales, and marketing, providing him with a comprehensive view of the network’s $19 billion revenue engine. In his new capacity, he will lead the executive team and report to Ryan Roslansky, who now serves as Executive Vice President of both LinkedIn and Microsoft Office…

Posted On :
Category:

John Ternus Inherits Apple as Cook Era Comes to a Close

Apple is initiating its most significant leadership transition in over a decade as John Ternus prepares to take the helm as CEO on September 1, 2026. Tim Cook, who has served as the architect of Apple’s $4 trillion valuation, will move into the role of Executive Chairman. This upcoming transition marks the end of an era defined by Cook’s expansion into services and wearables, which transformed the company from a hardware-centric business into a diversified global powerhouse. Cook will remain active in the new structure, focusing on high-level board governance and international policy engagement…

Posted On :